With the underlying obstructions of the immune system to eradicate cancer, each step can be targeted to address these challenges using multiple therapeutic cancer vaccines, which contribute to triggering the antigen-specific CD8+ T cell response18. The gene discussed is CD8A; the disease is cancer.